Frank D. King

7.5k total citations · 1 hit paper
135 papers, 5.2k citations indexed

About

Frank D. King is a scholar working on Organic Chemistry, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Frank D. King has authored 135 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Organic Chemistry, 35 papers in Molecular Biology and 26 papers in Materials Chemistry. Recurrent topics in Frank D. King's work include Asymmetric Synthesis and Catalysis (16 papers), Synthesis and Biological Evaluation (15 papers) and Synthesis and Catalytic Reactions (13 papers). Frank D. King is often cited by papers focused on Asymmetric Synthesis and Catalysis (16 papers), Synthesis and Biological Evaluation (15 papers) and Synthesis and Catalytic Reactions (13 papers). Frank D. King collaborates with scholars based in United Kingdom, United States and Germany. Frank D. King's co-authors include Graham J. Hutchings, Jianliang Xiao, Xiaoguang Li, Paul McMorn, Xiaofeng Wu, Colin H. Rochester, Donald Bethell, Philip C. Bulman Page, Frederick E. Hancock and Fred Hancock and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and The Journal of Physical Chemistry B.

In The Last Decade

Frank D. King

134 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions

2005 897 citations Yi‐Jun Xu, Patrick Jenkins et al. Nature profile →

Peers

Countries citing papers authored by Frank D. King

Since Specialization

Citations

This map shows the geographic impact of Frank D. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank D. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank D. King more than expected).

Fields of papers citing papers by Frank D. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank D. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank D. King. The network helps show where Frank D. King may publish in the future.

Co-authorship network of co-authors of Frank D. King

This figure shows the co-authorship network connecting the top 25 collaborators of Frank D. King. A scholar is included among the top collaborators of Frank D. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank D. King. Frank D. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triflic acid-mediated phenylation of N-acylaminoalkyl diethylacetals and N-acyl-2-phenyl cyclic amides 2011 ·Organic & Biomolecular Chemistry ·Frank D. King, Stephen Caddick	20
2	A facile synthesis of dibenzopyrroloazepinones as tetracyclic allocolchicinoids—an unusual 1,2-phenyl shift 2009 ·Chemical Communications ·Liang Wu, Abil E. Aliev, Stephen Caddick, Richard J. Fitzmaurice, Derek A. Tocher, Frank D. King	9
3	Insight into and Practical Application of pH‐Controlled Asymmetric Transfer Hydrogenation of Aromatic Ketones in Water 2005 ·Angewandte Chemie International Edition ·Xiaofeng Wu, Xiaoguang Li, Frank D. King, Jianliang Xiao	191
4	The identification of potent and selective imidazole-based inhibitors of B-Raf kinase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Andrew K. Takle, Murray J. B. Brown, Susannah Davies, David K. Dean, (unknown), Alessandra Gaiba, (unknown), Frank D. King, Peter J. Lovell, A. Naylor, Alastair D. Reith, Jon G.A. Steadman, David M. Wilson	170
5	Effect of structure of the redox molecular sieve TS-1 on the oxidation of phenol, crotyl alcohol and norbornylene 2005 ·Physical Chemistry Chemical Physics ·(unknown), Paul McMorn, Donald Bethell, Frank D. King, Frederick E. Hancock, Andrew Burrows, Christopher J. Kiely, Simon Ellwood, Graham J. Hutchings	25
6	Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions breakdown → 2005 ·Nature ·(unknown), Yi‐Jun Xu, Patrick Jenkins, Paul McMorn, Philip Landon, Dan I. Enache, Albert F. Carley, Gary A. Attard, Graham J. Hutchings, Frank D. King, E. Hugh Stitt, Peter Johnston, Ken Griffin, Christopher J. Kiely	897
7	A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Steven M. Bromidge, David Clapham, Frank D. King, Peter J. Lovell, (unknown), (unknown), Vicky Holland, Graham J. Riley, Kathryn R. Starr, Brenda Trail, Martyn Wood	14
8	Accelerated asymmetric transfer hydrogenation of aromatic ketones in water 2004 ·Organic & Biomolecular Chemistry ·Xiaofeng Wu, Xiaoguang Li, William P. Hems, Frank D. King, Jianliang Xiao	193
9	Observation of the enhancement in enantioselectivity with conversion for the aziridination of styrene using copper bis(oxazoline) complexesElectronic supplementary information (ESI) available: further data. See http://www.rsc.org/suppdata/cc/b3/b309507j/ 2003 ·Chemical Communications ·(unknown), Sophia Taylor, (unknown), Paul McMorn, (unknown), Donald Bethell, Philip C. Bulman Page, Frederick E. Hancock, Frank D. King, Graham J. Hutchings	17
10	Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists 2002 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Stephen E. Clarke, Frank D. King, Peter J. Lovell, Helen Newman, Graham J. Riley, Carol Routledge, Halina T. Serafinowska, Douglas R. Smith, David R. Thomas	12
11	Oxidation of crotyl alcohol using Ti-β and Ti-MCM-41 catalysts 2001 ·Journal of Molecular Catalysis A Chemical ·(unknown), Paul McMorn, Donald Bethell, Philip C. Bulman Page, Frank D. King, Frederick E. Hancock, Graham J. Hutchings	47
12	Drug discoverers – you need us! – Reply 2001 ·Drug Discovery Today ·Frank D. King	2
13	From CO2 to Methanol by Hybrid QM/MM Embedding This work was supported by EU Esprit IV project 25047. S.A.F. is grateful to ICI and Synetix for funding. K. Waugh, L. Whitmore, S. Cristol, and P. Sushko are thanked for their helpful insights. QM/MM=quantum mechanics/molecular mechanics. 2001 ·Angewandte Chemie International Edition ·Samuel A. French, Alexey A. Sokol, Stefan T. Bromley, C. Richard A. Catlow, Stephen C. Rogers, Frank D. King, Paul Sherwood	100
14	1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents 2000 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Steven Dabbs, Susannah Davies, D. Malcolm Duckworth, Ian T. Forbes, Graham E. Jones, (unknown), Frank D. King, (unknown), Thomas P. Blackburn, Vicky Holland, G.A. Kennett, Sean Lightowler, Derek N. Middlemiss, Graham J. Riley, Brenda Trail, Martyn Wood	16
15	1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Susannah Davies, D. Malcolm Duckworth, Ian T. Forbes, Graham E. Jones, (unknown), Frank D. King, Thomas P. Blackburn, Vicky Holland, G.A. Kennett, Sean Lightowler, Derek N. Middlemiss, Graham J. Riley, Brenda Trail, Martyn Wood	10
16	Comparison of the Cardiovascular Effects of the Novel 5-HT1B/1D Receptor Agonist, SB 209509 (VML251), and Sumatriptan in Dogs 1997 ·Journal of Cardiovascular Pharmacology ·Andrew A. Parsons, Stephen Parker, Pravin Raval, Colin A. Campbell, Vahn A. Lewis, (unknown), Andrea Hunter, Thomas C. Hamilton, Frank D. King	24
17	Serotonin 5-HT3 and 5-HT4 receptor antagonists 1997 ·Medicinal Research Reviews ·Laramie M. Gaster, Frank D. King	73
18	Azabicyclic indole esters as potent 5-HT4 receptor antagonists 1996 ·Bioorganic & Medicinal Chemistry ·Paul Wyman, Laramie M. Gaster, Frank D. King, (unknown), E.S. Ellis, Kay A. Wardle, Timothy J. Young	8
19	Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist 1994 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Alberto J. Kaumann, Laramie M. Gaster, Frank D. King, Anthony M. Brown	26
20	BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties 1993 ·Psychopharmacology ·Thomas P. Blackburn, Gordon S. Baxter, G.A. Kennett, Frank D. King, D.C Piper, Gareth J. Sanger, David R. Thomas, N. Upton, Martyn Wood	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact